相关实验视频
Updated: Jun 5, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
恶性皮肤附带瘤的临床特征和预后:使用日本数据库进行的一项回顾性研究
Shogo Wada1, Taisuke Ishii2, Dai Ogata1
1Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Journal of surgical oncology
|December 9, 2024
概括
这项研究分析了患有恶性皮肤附带瘤 (MCAT) 的亚洲患者,揭示了关键的预后因素. 与其他种群相比,研究结果突出了MCAT特征和生存结果的差异.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 流行病学 流行病学
背景情况:
- 恶性皮肤副瘤 (MCAT) 是一种罕见的皮肤癌.
- 之前对MCAT的研究主要集中在高加索人群上.
- 亚洲人群中MCAT的临床特征和预后仍未得到充分研究.
研究的目的:
- 研究亚洲患者诊断患有MCAT的临床特征和生存结果.
- 确定影响亚洲队列中MCAT预后的因素.
- 将发现与其他族群的现有数据进行比较.
主要方法:
- 使用日本数据库 (2012-2015) 的回顾性研究.
- 包括来自医院癌症登记和诊断程序组合的数据.
- 使用卡普兰-梅尔方法和考克斯回归分析患者特征和生存数据.
主要成果:
- 总共有1930名患者被分析,平均年龄为76岁.
- 脂质腺癌是最常见的亚型 (41.6%),其次是多瘤 (21.7%).
- 5年总生存率为72.3%;女性性别是一个有利的因素,而晚年,阶段≥II和螺旋腺癌是不利的因素.
结论:
- 根据亚型和族群,MCAT的特征和预后会有所不同.
- 这项研究为亚洲人群中的MCAT提供了关键的见解.
- 需要进一步的研究来了解这一队列与其他数据库之间观察到的差异.
更多相关视频
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.4K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
217
相关概念视频
Skin Cancer
3.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.4K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328